Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
Recruiting · NCT07220694 · Registry updated 2026-01-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance | Cognition Disorders, Cognitive Decline, Cognitive Dysfunction, Insulin Resistance, Mild Cognitive Impairment, Nutritional and Metabolic Diseases, cognitive disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, nervous system disorder, neurodegenerative disease, psychiatric disorder | Recruiting | Not applicable | 2026-01-28 | NCT07220694 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sabinsa Corporation | 2 |
| SF Research Institute, Inc. | 10 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| San Francisco Research Institute | San Francisco | United States | 9 |